Variants
Sign InSign Up

rs751870618

  • Uncertain significance

Your Genotype

Sign In

Description

The N87S variant in the COG6 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The N87S variant was not observed at any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The N87S variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret N87S as a variant of uncertain significance.

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Reference Allele

A


Alternative Allele

G

Chromosome

13


Location

39659470


Variant Type

SNP

Genes

ClinVar

Name

NM_020751.3(COG6):c.260A>G (p.Asn87Ser)


Allele

G


Clinical Significance

Uncertain significance

© 2024 Biocodify. All rights reserved.

TwitterTwitter

Product

HomePricingDashboard

Stay up to date

The latest news and updates from Biocodify, sent to your inbox.